PF-04856883

PF-04856883 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-04856883, covering 2018-02-09 to 2018-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females [Phase 1]

See pricing